Recent developments on JAK2 inhibitors: a patent review

Author： Kiss Róbert   Sayeski Peter P   Keserű György M  

Publisher： Informa Healthcare

ISSN： 1354-3776

Source： Expert Opinion on Therapeutic Patents, Vol.20, Iss.4, 2010-04, pp. : 471-495

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Inhibitors of JAK2 and JAK3: an update on the patent literature 2010 – 2012

By Dymock Brian W   See Cheng Shang  

Expert Opinion on Therapeutic Patents, Vol. 23, Iss. 4, 2013-04 ,pp. : 449-501

Informa Healthcare

Access to resources Recommend Favorite

Inhibitors of PDE4: a review of recent patent literature

By Odingo Joshua O  

Expert Opinion on Therapeutic Patents, Vol. 15, Iss. 7, 2005-07 ,pp. : 773-787

Informa Healthcare

Access to resources Recommend Favorite

5-Lipoxygenase inhibitors: a review of recent developments and patents

By Pergola Carlo   Werz Oliver  

Expert Opinion on Therapeutic Patents, Vol. 20, Iss. 3, 2010-03 ,pp. : 355-375

Informa Healthcare

Access to resources Recommend Favorite

Protein kinase CK2 inhibitors: a patent review

By Cozza Giorgio   Pinna Lorenzo A   Moro Stefano  

Expert Opinion on Therapeutic Patents, Vol. 22, Iss. 9, 2012-09 ,pp. : 1081-1097

Informa Healthcare

Access to resources Recommend Favorite

Tubulin inhibitors: a patent review

By Liu Yi-Min   Chen Hsiao-Ling   Lee Hsueh-Yun   Liou Jing-Ping  

Expert Opinion on Therapeutic Patents, Vol. 24, Iss. 1, 2014-01 ,pp. : 69-88

Informa Healthcare

Access to resources Recommend Favorite